These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 16998319

  • 1. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS.
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [Abstract] [Full Text] [Related]

  • 2. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS.
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transient leukemia in newborns with Down syndrome.
    Massey GV.
    Pediatr Blood Cancer; 2005 Jan; 44(1):29-32. PubMed ID: 15558701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C, Creutzig U, Reinhardt D.
    Klin Padiatr; 2005 Jan; 217(3):126-34. PubMed ID: 15858703
    [Abstract] [Full Text] [Related]

  • 8. GATA1 mutations in acute leukemia in children with Down syndrome.
    Magalhães IQ, Splendore A, Emerenciano M, Figueiredo A, Ferrari I, Pombo-de-Oliveira MS.
    Cancer Genet Cytogenet; 2006 Apr 15; 166(2):112-6. PubMed ID: 16631466
    [Abstract] [Full Text] [Related]

  • 9. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G, Merlo P.
    Lab Hematol; 2003 Apr 15; 9(1):38-41. PubMed ID: 12661826
    [Abstract] [Full Text] [Related]

  • 10. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
    Miyauchi J, Ito Y, Tsukamoto K, Takahashi H, Ishikura K, Sugita K, Miyashita T.
    Br J Haematol; 2010 Mar 15; 148(6):898-909. PubMed ID: 20064153
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A, Brown EJ, Christensen H, Doyle J.
    Clin Lab Med; 1999 Mar 15; 19(1):157-67, vii. PubMed ID: 10403079
    [Abstract] [Full Text] [Related]

  • 13. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.
    Leuk Res; 2005 Nov 15; 29(11):1353-6. PubMed ID: 15916804
    [Abstract] [Full Text] [Related]

  • 14. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
    Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas P, Vora A.
    Br J Haematol; 2005 Feb 15; 128(4):548-51. PubMed ID: 15686466
    [Abstract] [Full Text] [Related]

  • 15. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
    Roy A, Roberts I, Norton A, Vyas P.
    Br J Haematol; 2009 Oct 15; 147(1):3-12. PubMed ID: 19594743
    [Abstract] [Full Text] [Related]

  • 16. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
    Fuster Soler JL, Norton A, Galera Miñarro A, Bermúdez Cortés M, Llinares Riestra ME, Ortuño Giner F.
    An Pediatr (Barc); 2011 Jan 15; 74(1):31-7. PubMed ID: 20870473
    [Abstract] [Full Text] [Related]

  • 17. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
    Apollonsky N, Shende A, Ouansafi I, Brody J, Atlas M, Aygun B.
    J Pediatr Hematol Oncol; 2008 Nov 15; 30(11):860-4. PubMed ID: 18989165
    [Abstract] [Full Text] [Related]

  • 18. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.
    Sandoval C, Pine SR, Guo Q, Sastry S, Stewart J, Kronn D, Jayabose S.
    Pediatr Blood Cancer; 2005 Jan 15; 44(1):85-91. PubMed ID: 15390279
    [Abstract] [Full Text] [Related]

  • 19. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E.
    J Pediatr Hematol Oncol; 2006 Oct 15; 28(10):696-8. PubMed ID: 17023834
    [Abstract] [Full Text] [Related]

  • 20. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD.
    Blood Cells Mol Dis; 2003 Oct 15; 31(3):351-6. PubMed ID: 14636651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.